---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-017827"
form_type: "8-K"
ticker: "HIND"
cik: "0001427570"
company_name: "Vyome Holdings, Inc"
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T19:49:35.862675+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# ReShape Q3 revenue down 24.5% to $2.8M; non-GAAP adj. EBITDA loss $4.3M

## Summary
- Revenue $2.8M for Q3 2022, down 24.5% YoY from $3.7M due to European sales decline.
- Gross margin improved to 75.1% from 57.6%, driven by higher domestic sales mix and cost cuts.
- Non-GAAP adjusted EBITDA loss widened to $4.3M from $3.6M in Q3 2021.
- Cash and equivalents $6.1M as of Sep 30, 2022; company remains debt-free.
- Appointed new CEO Paul F. Hickey in August; received FDA 510(k) clearance for GIBI HD tube.

## SEC filing metadata
- accession: 0001558370-22-017827
- form_type: 8-K
- ticker: HIND
- cik: 0001427570
- company_name: Vyome Holdings, Inc
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427570/000155837022017827/0001558370-22-017827-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427570/000155837022017827/rsls-20221114x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-017827
- JSON: https://secwatch.observer/filing/0001558370-22-017827.json
- Plain text: https://secwatch.observer/filing/0001558370-22-017827.txt

## Key facts
- Earnings Releases
  Vyome Holdings, Inc reported financial results for the three and nine months ended September 30, 2022.
  - Period: the three and nine months ended September 30, 2022
  - Result: reported results
  source text: ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today reported financial and operating results for the third quarter ended September 30, 2022 and provided a corporate strategic update.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1427570/000155837022017827/0001558370-22-017827-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.